1.Restoration of Blood Pressure after Administering Methylene Blue for Vasoplegic Syndrome, which Developed after Open Heart Surgery for Septic Infective Endocarditis: A case report.
Sak LEE ; Mi Kyung BAE ; Gi Jong YI ; Young Nam YOUN ; Suk Won SONG ; Do Kyun KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2007;40(4):305-308
Vasoplegic syndrome occurs in 8~10% of patients following cardiac surgery, and this happens in part because of inducing the inflammatory response. Nitric oxide and guanylate cyclase play an important role in this response, and this is associated with increased morbidity and mortality. For our case, we administered methylene blue (MB), an inhibitor of guanylate cyclase, early after performing cardiopulmonary bypass in a patient with vasoplegic syndrome. The patient recovered immediately after MB administration and maintained an optimal blood pressure without the aid help of any vasopressors.
Blood Pressure*
;
Cardiopulmonary Bypass
;
Endocarditis*
;
Guanylate Cyclase
;
Heart*
;
Humans
;
Methylene Blue*
;
Mortality
;
Nitric Oxide
;
Thoracic Surgery*
;
Vasoplegia*
2.Methylene Blue for Vasoplegic Syndrome after Cardiopulmonary Bypass: A case report.
Ji Yeon LEE ; Min Huiy LEE ; Jong Wha LEE
Korean Journal of Anesthesiology 2008;54(6):677-681
Vasoplegic syndrome (VS) occurs in 8-10% of patients following cardiac surgery and is associated with increased morbidity and mortality. Nitric oxide and guanylate cyclase play an important role in this response. Methylene blue, an inhibitor of guanylate cyclase, has recently been advocated as an adjunct in the treatment of catecholamine-refractory VS. We experienced a case of VS after aortic arch replacement surgery, presenting severe hypotension refractory to high-dose norepinephrine and vasopressin. Administration of methylene blue 100 mg led to immediate recovery of arterial pressure. We report this case and review the role of methylene blue in the treatment of catecholamine-refractory VS.
Aorta, Thoracic
;
Arterial Pressure
;
Guanylate Cyclase
;
Humans
;
Hypotension
;
Methylene Blue
;
Nitric Oxide
;
Norepinephrine
;
Thoracic Surgery
;
Vasoplegia
;
Vasopressins
3.Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery: A case report
In Duk OH ; Eunsil SHIN ; Jong Mi JEON ; Hyunho WOO ; Jeong Hyun CHOI
Anesthesia and Pain Medicine 2019;14(4):460-464
BACKGROUND: Vasoplegic syndrome is an increasingly recognized disease in perioperative medicine and is characterized by severe hypotension, normal or elevated cardiac output, and decreased systemic vascular resistance. It occurs commonly after cardiopulmonary bypass but may also occur after other types of surgery.CASE: Vasoplegic syndrome developed in our patient during posterior lumbar interbody fusion because of administering nicardipine after phenylephrine. However, the blood pressure did not increase as expected despite simultaneous use of norepinephrine and vasopressin to increase the reduced systemic vascular resistance.CONCLUSIONS: We present a case of vasoplegic syndrome that developed during posterior lumbar interbody fusion and was treated successfully with methylene blue.
Blood Pressure
;
Cardiac Output
;
Cardiopulmonary Bypass
;
Humans
;
Hypotension
;
Methylene Blue
;
Nicardipine
;
Norepinephrine
;
Phenylephrine
;
Vascular Resistance
;
Vasoplegia
;
Vasopressins
4.Effect of a single bolus of methylene blue prophylaxis on vasopressor and transfusion requirement in infective endocarditis patients undergoing cardiac surgery.
Jin Sun CHO ; Jong Wook SONG ; Sungwon NA ; Joo Hwa MOON ; Young Lan KWAK
Korean Journal of Anesthesiology 2012;63(2):142-148
BACKGROUND: The accentuated nitric oxide (NO) release that is induced by the systemic inflammatory response associated with infective endocarditis (IE) and cardiopulmonary bypass (CPB) may result in catecholamine refractory hypotension (vasoplegia) and increased transfusion requirement due to platelet inhibition. Methylene blue (MB) is an inhibitory drug of inducible NO. We aimed to evaluate the effect of prophylactic MB administration before CPB on vasopressor and transfusion requirements in patients with IE undergoing valvular heart surgery (VHS). METHODS: Forty-two adult patients were randomly assigned to receive 2 mg/kg of MB (MB group, n = 21) or saline (control group, n = 21) for 20 min before the initiation of CPB. The primary end points were comparisons of vasopressor requirements serially assessed after weaning from CPB and hemodynamic parameters serially recorded before and after CPB. The secondary endpoint was the comparison of transfusion requirements. RESULTS: Two patients in the control group received MB after weaning from CPB due to norepinephrine and vasopressin refractory vasoplegia and were thus excluded. There were no significant differences in vasopressor requirements and hemodynamic parameters between the two groups. The mean number of units of packed erythrocytes transfused per transfused patient was significantly less in the MB group. The numbers of patients transfused with fresh frozen plasma and platelet concentrates were less in the MB group. CONCLUSIONS: In IE patients undergoing VHS, prophylactic MB administration before CPB did not confer significant benefits in terms of vasopressor requirements and hemodynamic parameters, but it was associated with a significant reduction in transfusion requirement.
Adult
;
Blood Platelets
;
Cardiopulmonary Bypass
;
Endocarditis
;
Erythrocytes
;
Hemodynamics
;
Humans
;
Hypotension
;
Methylene Blue
;
Nitric Oxide
;
Norepinephrine
;
Plasma
;
Thoracic Surgery
;
Vasoplegia
;
Vasopressins
;
Weaning
5.Moderate and Deep Hypothermia Produces Hyporesposiveness to Phenylephrine in Isolated Rat Aorta.
Jun Woo CHO ; Chul Ho LEE ; Jae Seok JANG ; Oh Choon KWON ; Woon Seok ROH ; Jung Eun KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2013;46(6):402-412
BACKGROUND: Moderate and severe hypothermia with cardiopulmonary bypass during aortic surgery can cause some complications such as endothelial cell dysfunction or coagulation disorders. This study found out the difference of vascular reactivity by phenylephrine in moderate and severe hypothermia. METHODS: Preserved aortic endothelium by excised rat thoracic aorta was sectioned, and then down the temperature rapidly to 25degrees C by 15 minutes at 38degrees C and then the vascular tension was measured. The vascular tension was also measured in rewarming at 25degrees C for temperatures up to 38degrees C. To investigate the mechanism of the changes in vascular tension on hypothermia, NG-nitro-L-arginine methyl esther (L-NAME) and indomethacin administered 30 minutes before the phenylephrine administration. And to find out the hypothermic effect can persist after rewarming, endothelium intact vessel and endothelium denuded vessel exposed to hypothermia. The bradykinin dose-response curve was obtained for ascertainment whether endothelium-dependent hyperpolarization factor involves decreasing the phenylnephrine vascular reactivity on hypothermia. RESULTS: Fifteen minutes of the moderate hypothermia blocked the maximum contractile response of phenylephrine about 95%. The vasorelaxation induced by hypothermia was significantly reduced with L-NAME and indomethacin administration together. There was a significant decreasing in phenylephrine susceptibility and maximum contractility after 2 hours rewarming from moderate and severe hypothermia in the endothelium intact vessel compared with contrast group. CONCLUSION: The vasoplegic syndrome after cardiac surgery might be caused by hypothermia when considering the vascular reactivity to phenylephrine was decreased in the endothelium-dependent mechanism.
Animals
;
Aorta*
;
Aorta, Thoracic
;
Biological Factors
;
Bradykinin
;
Cardiopulmonary Bypass
;
Endothelial Cells
;
Endothelium
;
Epoprostenol
;
Hypothermia*
;
Indomethacin
;
NG-Nitroarginine Methyl Ester
;
Nitric Oxide
;
Nitroarginine
;
Phenylephrine*
;
Rats*
;
Rewarming
;
Thoracic Surgery
;
Vasodilation
;
Vasoplegia